Stock Market News Review: SPY, QQQ Tick Higher as U.S.-China Trade Talks End, Inflation Expectations Drop
Both the S&P 500 (SPX) and the Nasdaq 100 (NDX) barely managed to finish Monday in positive territory following steep declines during the last trading hour.
Confident Investing Starts Here:
This morning, the U.S. and China began their second round of trade talks. At the center of discussions are China's export curbs on rare earth minerals, which are used in everything from chips to smartphones to electric vehicles. According to the Financial Times, the U.S. is considering easing restrictions on its chip exports if China agrees to increase the flow of its rare earths to the U.S. The U.S. is also considering easing restrictions on semiconductor software, aircraft parts, and ethane as it brings bargaining chips to the table.
'Our expectation is that after the handshake, then immediately after the handshake, any export controls from the U.S. will be eased, and the rare earths will be released in volume, and then we can go back to negotiating smaller matters,' said White House economic advisor Kevin Hassett.
While day one of the discussions, which lasted roughly six hours, has ended, the negotiations will continue tomorrow morning. Treasury Secretary Scott Bessent described the conversation as a 'good meeting' while Commerce Secretary Howard Lutnick characterized it as 'fruitful.' Both men didn't provide any further details. President Trump said that the talks went well and that China should open itself up for trade.
Meanwhile, inflation expectations are falling across the board. After rising to 3.6% in April following President Trump's reciprocal tariffs, the one-year inflation expectation for May dropped to 3.2%, according to the New York Fed's May Survey of Consumer Expectations. Long-term inflation expectations fell too, with the three-year at 3.0% and the five-year at 2.6%, down by 0.2% and 0.1%, respectively. On top of that, the corporate earnings growth outlook is rising, with the median one-year-ahead earnings growth expectation increasing by 0.2% to 2.7%.
The S&P 500 ended the trading session with a 0.09% gain while the Nasdaq 100 fared slightly better with a 0.17% rise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
23 minutes ago
- Boston Globe
US imposes sanctions on a Palestinian NGO and other charities, accusing them ties to militant groups
The federal government claims that Addameer 'has long supported and is affiliated' with the Popular Front for the Liberation of Palestine, a secular, left-wing movement with a political party and an armed wing that has carried out deadly attacks against Israelis. Israel and the United States have labeled the PFLP a terrorist organization. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Addameer did not immediately have a comment on the sanctions. Advertisement Israel has alleged that Addameer funds terrorism, a claim that the United Nations previously said it could not support with compelling evidence. In a 2022 The organization also works with Amnesty International, Human Rights Watch and is a member of the World Organization Against Torture. Israel's 2022 storming of Addameer's offices, prompted a rebuke from the UN, who said in a statement that Israel had not provided convincing evidence to support the claim. The UN said Addameer was conducting 'critical human rights, humanitarian and development work in the Occupied Palestinian Territory.' Advertisement In February, Zachor Legal Institute, an Israeli-American advocacy group that says it focuses on combatting antisemitism and terrorism, requested Addameer be added to Treasury's sanctions list. Marc Greendorfer, president of Zachor Legal Institute said in an email to the Associated Press that his group is 'very pleased to see Treasury following up on our request.' He said the federal government should act 'to prevent hostile foreign actors from spreading hate and violence in the United States. We applaud Treasury's action and encourage Treasury to expand its focus to the other groups that we identified.' Other entities hit with sanctions Tuesday include: The Gaza-based charity Al Weam Charitable Society and its leader The Turkish charity Filistin Vakfi and its leader El Baraka Association for Charitable and Humanitarian Work and its leader The Netherlands-based Israa Charitable Foundation Netherlands and two employees The Italy-based Associazione Benefica La Cupola d'Oro A Because the majority of crowdfunding activity is legitimate, 'this status can make it more difficult for law enforcement attempting to investigate potential (terrorist financing) cases with a crowdfunding and online fundraising nexus,' the report said. Frankel reported from Jerusalem.
Yahoo
25 minutes ago
- Yahoo
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
'So bad, it's good': History shows the market's smallest stocks may be poised for a rebound after record underperformance
Small-cap stocks look poised for a rebound this month after tariff-related losses. Historically, June sees strong small-cap performance due to FTSE Russell index rebalancing. Cheap valuations, potential rate cuts, and AI adoption could drive a small-cap resurgence. Small-cap stocks were hammered in the aftermath of President Donald Trump's tariffs, but the stage looks set for a rebound this June. The small-cap track record has been grim recently: the Russell 2000 has seen its worst streak of underperformance relative to the S&P 500 since the dot-com era, and this past May marked the sixth-worst year-to-date performance since 1990. Small caps, initially perceived as a clear winner of the Trump trade following the election, have emerged as the biggest losers of the trade war. With tariff concerns top-of-mind, investors are viewing small caps as "price takers, not price makers," extra vulnerable to inflation and supply chain disruptions, a note by Evercore ISI senior managing direction, Julian Emanuel, said. But for the optimists, once you hit rock bottom, the only direction to go is up. In the eyes of Evercore, small caps have become "so bad, they're good." June has historically been a strong month for small caps, as the FTSE Russell rebalances its indexes and adds or removes stocks based on market cap criteria. This leads to a surge of trading activity that can boost stock prices. This effect is particularly prominent in the wake of outsized underperformance. In the five other instances of disappointing January to May performance, small caps exhibited strong seasonal reversion during the month of June, outperforming large caps by an average of 4.1%, Evercore said. The firm believes the market has moved past the point of peak tariff uncertainty, which could further boost the sector's performance in June. There are other catalysts for a small-cap resurgence as well. Amy Zhang, a portfolio manager at investment management firm Alger, pointed to cheap valuations and the potential for rate cuts. Small caps have historically traded at a 27% premium relative to large caps due to their higher growth expectations, but on a forward-looking basis, the Russell 2000 is currently only trading at a 11% premium to the S&P 500. This allows investors to get exposure to small caps at a steep discount relative to history, especially as fundamentals and the overall economic environment improve. Cheap valuations make small caps appealing takeover targets, and a pickup in M&A activity could help lift the group, Zhang told Business Insider. As large companies look to boost growth through acquisitions, smaller firms become prime candidates. The healthcare sector, the largest component of the Russell 2000, tends to benefit the most from increased dealmaking, according to Bank of America. Both Emanuel and Zhang believe lower rates, which help smaller companies with higher levels of debt on their balance sheets, could be coming later this year. "Because it's data dependent, they run the risk of being too late again," Zhang said of the Fed cutting rates. "I think it could be the case, like last year Q4, where the Fed may be in a position again to pivot to 50 basis points of cuts." Additionally, Zhang sees AI as a long-term tailwind for small caps. "AI is very deflationary, especially for labor costs," Zhang said. That means companies that adopt AI effectively can expand margins and boost productivity — advantages that could be especially powerful for smaller firms with with smaller budgets. Read the original article on Business Insider
